ELITechGroup Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ELITechGroup Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7305
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cystic fibrosis, hematology, microbiology and molecular diagnostics. Its clinical chemistry products comprise chemistry systems, open chemistry reagents, cystic fibrosis sweat tests, obstetric and pregnancy reagents, and osmometers. ELITech also offers various medical condition products such as bleeding and thrombotic disorders, human genetic, infectious diseases, streptococcus infections, anemia, autoimmune diseases, cancer, cardiovascular diseases, fungal infections, liver diseases and urinary tract infections, among others. The company serves clinical chemistry, microbiology, immunology, and molecular biology markets. It has operations in France, Brazil, the UK, the Netherlands, New Zealand, Switzerland, Italy and the US. Elitech is headquartered in Paris, Ile-de-France, France.

ELITechGroup Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ELITechGroup Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ELITechGroup Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ELITechGroup Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ELITechGroup Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ELITechGroup Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ELITechGroup Inc, Medical Equipment, Deal Details 10
Private Equity 10
PAI Partners to Acquire ELITech from Ergon Capital Partners 10
Partnerships 11
Integrated DNA Enters into Licensing Agreement with EliTech 11
ELITechGroup and R-Biopharm Enter into Agreement 12
Precision System Science Enters Into Co-Development Agreement With Elitech 13
Curetis Enters Into Distribution Agreement With Elitech 14
Phthisis Diagnostics Enters Into Distribution Agreement With Elitech Group 15
Acquisition 16
Elitech Acquires Vital Diagnostics, Maker Of Clinical Chemistry And Hematology Analyzers 16
ELITechGroup Inc – Key Competitors 17
ELITechGroup Inc – Key Employees 18
ELITechGroup Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Other Significant Developments 20
Aug 08, 2018: PSS basically agreed with ELITech on new development and supply of the system (on an OEM basis) 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
ELITechGroup Inc, Medical Equipment, Key Facts 2
ELITechGroup Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ELITechGroup Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ELITechGroup Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ELITechGroup Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ELITechGroup Inc, Deals By Market, 2012 to YTD 2018 8
ELITechGroup Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PAI Partners to Acquire ELITech from Ergon Capital Partners 10
Integrated DNA Enters into Licensing Agreement with EliTech 11
ELITechGroup and R-Biopharm Enter into Agreement 12
Precision System Science Enters Into Co-Development Agreement With Elitech 13
Curetis Enters Into Distribution Agreement With Elitech 14
Phthisis Diagnostics Enters Into Distribution Agreement With Elitech Group 15
Elitech Acquires Vital Diagnostics, Maker Of Clinical Chemistry And Hematology Analyzers 16
ELITechGroup Inc, Key Competitors 17
ELITechGroup Inc, Key Employees 18
ELITechGroup Inc, Subsidiaries 19

List of Figures
ELITechGroup Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ELITechGroup Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ELITechGroup Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ELITechGroup Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ELITechGroup Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ELITechGroup Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ELITechGroup Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ELITechGroup Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ELITechGroup Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bayer AG:企業の戦略・SWOT・財務情報
    Bayer AG - Strategy, SWOT and Corporate Finance Report Summary Bayer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Singapore Technologies Engineering Ltd (S63):企業の財務・戦略的SWOT分析
    Singapore Technologies Engineering Ltd (S63) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Kien Long Commercial Joint Stock Bank (KBC):企業の戦略的SWOT分析
    Kien Long Commercial Joint Stock Bank (KBC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • SUPERVALU INC.:戦略・SWOT・企業財務分析
    SUPERVALU INC. - Strategy, SWOT and Corporate Finance Report Summary SUPERVALU INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Onxeo SA (ONXEO):製薬・医療:M&Aディール及び事業提携情報
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as livatag, belchop, beleodaq, amep, asidna and validive, among others. It offers drugs for the treatment of …
  • Ak Bars Bank
    Ak Bars Bank - Strategy, SWOT and Corporate Finance Report Summary Ak Bars Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Prescient Therapeutics Ltd (PTX):企業の財務・戦略的SWOT分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a biotechnology company which develops novel medicines for cancer treatment. The company is investigating OmniCAR, an immune receptor platform that controls T-cell activity and multi-antigen targeting with a …
  • Procter & Gamble SA Pty Ltd:企業の戦略的SWOT分析
    Procter & Gamble SA Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Megapharm Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Megapharm Ltd (Megapharm) is a biotechnology company which offers marketing services. It is engaged in marketing of pharmaceutical products for international companies. Megapharm markets a wide range of products in various therapeutic areas such as dermatology, gastroenterology, central nerv …
  • Towngas China Co Ltd (1083):企業の財務・戦略的SWOT分析
    Summary Towngas China Co Ltd (Towngas China), a subsidiary of The Hong Kong and China Gas Co Ltd is an oil and gas company. The company's business activities include sale and distribution of pipeline gas, gas pipeline construction, operation of city-gas pipeline networks, operating fuel automobile r …
  • Phillips 66 Co (PSX)-石油・ガス分野:企業M&A・提携分析
    Summary Phillips 66 Company (Phillips 66) is a diversified energy manufacturing and logistics company. It gathers, processes, transports and markets natural gas and petroleum products such as gasoline, diesel, aviation fuel and lubricants, and transports, fractionates and markets natural gas liquids …
  • Sacgasco Ltd (SGC):企業の財務・戦略的SWOT分析
    Summary Sacgasco Ltd (Sacgasco) formerly Australian Oil Company Ltd, is an energy company that provides conventional oil and gas exploration, development and production across Australia. The company develops and produces clean natural gas in the Sacramento Basin, onshore California. It explores Sacr …
  • CorMedix Inc (CRMD):製薬・医療:M&Aディール及び事業提携情報
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Regen BioPharma Inc (RGBP):企業の財務・戦略的SWOT分析
    Summary Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, Dif …
  • ConMed Corp (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corp (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PDS Biotechnology Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops vaccines and immunotherapies for cancer and infectious disease. The company uses versamune technology that is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothera …
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):企業の財務・戦略的SWOT分析
    Summary Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (Guangzhou Baiyunshan Pharmaceutical) is a manufacturer of herbal medicine, chemical raw material medicine and preparation, biological medicine, and health products. The company also offers herbal tea, Chinese and Western medicine, intermed …
  • Arab National Bank:企業の戦略・SWOT・財務情報
    Arab National Bank - Strategy, SWOT and Corporate Finance Report Summary Arab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Louisiana-Pacific Corp (LPX):企業の財務・戦略的SWOT分析
    Louisiana-Pacific Corp (LPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Oil Search Ltd (Oil Search) is an independent upstream energy company. It explores for, develops and produces oil, natural gas and natural gas liquids (NGL). The company has majority of its oil and ga …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆